CD274 and neoplasm: It releases the suppression of the T cell-mediated antitumor immune response by blocking the interaction of PD-L1 with PD-1 receptors (adaptive immune response) and induces NK cell-mediated direct tumor cell lysis via antibody-dependent cell-mediated cytotoxicity (innate immune response) [17].